Difference between revisions of "Clarithromycin (Biaxin)"
Jump to navigation
Jump to search
(Created page with "==Diseases for which it is used== *Multiple myeloma") |
m |
||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| + | ==Mechanism of action== | ||
| + | Antibiotic which inhibits bacterial protein synthesis through binding to the 50S subunit. Mechanism for observed antineoplastic effect may be through suppression of IL-6. | ||
| + | |||
==Diseases for which it is used== | ==Diseases for which it is used== | ||
| + | *[[Diffuse large B-cell lymphoma]] | ||
| + | *[[B-cell lymphoma of mucosa-associated lymphoid tissue]] | ||
| + | |||
| + | ==Diseases for which it was used== | ||
*[[Multiple myeloma]] | *[[Multiple myeloma]] | ||
| + | |||
| + | ==Also known as== | ||
| + | *'''Brand name:''' Biaxin | ||
| + | |||
| + | [[Category:Drugs]] | ||
| + | [[Category:Oral medications]] | ||
| + | [[Category:Antibacterials]] | ||
| + | |||
| + | [[Category:Diffuse large B-cell lymphoma medications]] | ||
| + | [[Category:MALT lymphoma medications]] | ||
| + | [[Category:Multiple myeloma medications (historic)]] | ||
| + | |||
| + | [[Category:FDA approved in 1991]] | ||
Latest revision as of 19:05, 25 April 2022
Mechanism of action
Antibiotic which inhibits bacterial protein synthesis through binding to the 50S subunit. Mechanism for observed antineoplastic effect may be through suppression of IL-6.
Diseases for which it is used
Diseases for which it was used
Also known as
- Brand name: Biaxin